Prelude Therapeutics
PRLD · NASDAQ
$3.53+$0.14 (+4.13%)TodayMarket closed ·
Prev close $3.39
Who owns PRLD
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 61.3% of PRLD’s shares.
- OrbiMed Advisors, LLC17.2%
- Baker Bros. Advisors LP12.7%
- RA Capital Management, LP8.1%
- Incyte Corp5.5%
- Next 6 largest institutions17.7%
- All other shareholders38.7%
| Holder | Shares | % of shares |
|---|---|---|
| OrbiMed Advisors, LLC | 13.72M | 17.23% |
| Baker Bros. Advisors LP | 10.12M | 12.71% |
| RA Capital Management, LP | 6.48M | 8.13% |
| Incyte Corp | 4.37M | 5.49% |
| Vaddi (Krishna) | 3.67M | 4.61% |
| Soleus Capital Management, L.P. | 3.38M | 4.24% |
| Kynam Capital Management LP | 2.42M | 3.03% |
| Vanguard Capital Management, LLC | 2.01M | 2.52% |
| BlackRock Institutional Trust Company, N.A. | 1.60M | 2.01% |
| Sphera Funds Management Ltd. | 1.02M | 1.28% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.51M | 1.90% |
| iShares Russell 2000 ETF | 655.13K | 0.82% |
| Vanguard Extended Market Index Fund | 458.36K | 0.58% |
| Biotech Growth Trust PLC | 346.50K | 0.44% |
| Fidelity Small Cap Index Fund | 301.34K | 0.38% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $35.00M (6 trades) of PRLD on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Sandor Victor | Award | 38.00K | — |
| Dorton Katina | Award | 38.00K | — |
| Bonita David P | Award | 38.00K | — |
| Babler Martin | Award | 38.00K | — |
| FRIEDMAN PAUL A | Award | 38.00K | — |
| BAKER JULIAN | Award | 38.00K | — |
| BAKER JULIAN | Award | 38.00K | — |
| Morris Charles Q | Award | 450.00K | $2.11M |
| RA Capital Healthcare Fund LP | Other | 1.41M | — |
| RA Capital Healthcare Fund LP | Other | 1.41M | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 4.58M
- Days to cover
- 7.91
- % of shares outstanding
- 5.74%
- Average daily volume
- 578.22K
- Change since last report
- +26.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.